Primärprävention von Herz- und Gefäßerkrankungen
Zuletzt bearbeitet: Zuletzt revidiert:
Zuletzt revidiert von:Günther Egidi
- Deutsche Gesellschaft für Allgemeinmedizin (DEGAM). Leitlinie: Hausärztliche Risikoberatung zur kardiovaskulären Prävention. S3. Stand 2017. www.degam.de
- NVL-Programm von BÄK, KBV, AWMF. Nationale VersorgungsLeitlinie Chronische KHK. AWMF-Leitlinie Nr. nvl-004, Stand 2013. www.awmf.org
- The Emergency Risk Factors Collaboration. Separate and combined association of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011; : doi: 10.1016/S0140-6736(11)60105-0. DOI
- Myint PK, Kwok CS, Luben RN. Body fat percentage, body mass index and waist-to-hip ratio as predictors of mortality and cardiovascular disease. Heart 2014. doi:10.1136/heartjnl-2014-305816 DOI
- Lindhardsen J, Ahlehoff O, Gislason GH, et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 2011; 70: 929-934. PubMed
- Mehta NN, Yu Y, Pinnelas R, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 2011; 124: 775. PubMed
- Kavousi M, Elias-Smale S, Rutten JHW, et al. Evaluation of newer risk markers for coronary heart disease risk classification: A cohort study. Ann Intern Med 2012; 156: 438-44. Annals of Internal Medicine
- Lorenz MW, Polak JF, Kavousi M, et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet 2012; 379: 2053-62. PubMed
- Den Ruijter HM, Peters SA, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 2012; 308: 796-803. Journal of the American Medical Association
- Deutsche Gesellschaft für Allgemeinmedizin (DEGAM). Leitlinie: Hausärztliche Risikoberatung zur kardiovaskulären Prävention. S3. Stand 2017. www.degam.de
- Dehghan M, Mente A, Rangarajan S, et al. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study. Lancet 2018; 392: 2288-97. pmid:30217460. www.ncbi.nlm.nih.gov
- van Wyk H, Davis RE, Davis JS. A critical review of low-carbohydrate diets in people with type 2 diabetes. Diabetes Med. 2016;33:148. www.ncbi.nlm.nih.gov
- Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2013; 1: CD004816. Cochrane (DOI)
- Ray KK, Seshasai SR, Erqou S, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65229 participants. Arch Intern Med 2010; 170: 1024-31. PubMed
- Alpérovitch A, Kurth T, Bertrand M, et al. Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study. BMJ 2015; 350: h2335. doi:10.1136/bmj.h2335 DOI
- Freitag M. Satintherapie bei älteren Patienten in der Primärprävention? Arzneiverordnung in der Praxis (AVP) Arzneimittelkommission der deutschen Ärzteschaft, AkdÄ, 2019. (vorab online) www.akdae.de
- 35. Gemeinsamer Bundesausschuss (GBA). Anlage III – Übersicht über Verordnungseinschränkungen und -ausschlüsse in der Arzneimittelversorgung durch die Arzneimittel-Richtlinie und aufgrund anderer Vorschriften (§ 34 Absatz 1 Satz 6 und Absatz 3 SGB V; 2016 [zuletzt geprüft am:02.09.2016]. www.g-ba.de
- Diao D, Wright JM, Cundiff DK, et al. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev 2012 Aug 15;8:CD006742 Cochrane (DOI)
- Barnett H, Burrill P, Iheanacho I. Don't use aspirin for primary prevention of cardiovascular disease. BMJ 2010; 340: c1805. BMJ (DOI)
- ASCEND Study Collaborative Group. Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. N Engl J Med. 2018 Aug 26. doi: 10.1056/NEJMoa1804988. PMID: 30146931 www.ncbi.nlm.nih.gov
- Gaziano JM, Brotons C, Coppolecchia R et al.. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.. Lancet 2018; 392: 1036-1046. pmid:30158069 PubMed
- McNeil JJ, Wolfe R, Woods RL et al . Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.. N Engl J Med 2018; 379: 1509-18. pmid:30221597 PubMed
- Rothwell PM, Cook NR, Gaziano M, et al. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials. Lancet 2018. pmid:30017552 www.ncbi.nlm.nih.gov
- Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013 Oct 23;310(16):1711-20. PubMed
- Chowdhury R, Warnakula S, Kunutsor S, et al. Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk: A Systematic Review and Meta-analysis. Ann Intern Med. 2014 Mar 18;160(6). doi: 10.7326/M13-1788 DOI
- The ASCEND Study Collaborative Group: Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus. N Engl J Med. 2018. PMID: 30146932 www.ncbi.nlm.nih.gov
- Abdelhamid AS, Brown TJ, Brainard JS et al.Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2018. PMID: 30019766 www.ncbi.nlm.nih.gov
- Christoffersen M, Frikke-Schmidt R, Schnohr P, et al. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in generel population. BMJ 2011; 343: d5497. BMJ (DOI)
- Sesso HD, Christen WG, Bubes V, et al. Multivitamins in the Prevention of Cardiovascular Disease in Men: The Physicians` Health Study II Randomized Controlled Trial. JAMA 2012 Nov 7; 308(17): 1751-60. PubMed
- Myung SK, Ju W, Cho B, et al. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 346: f10. BMJ (DOI)
- Jorgensen T, Jacobsen RK, Toft U, et al. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ. 2014 Jun 9;348:g3617. doi: 10.1136/bmj.g3617 DOI
- Günther Egidi, Dr. med., Arzt für Allgemeinmedizin, Bremen (Review)
- Ingard Løge, spesialist allmennmedisin, universitetslektor, institutt for sammfunsmedisinske fag, NTNU, redaktør NEL